Terms: = Prostate cancer AND ER, estrogen receptor
1591 results:
1. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
2. Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores.
Rico-Fuentes C; López-Pulido EI; Pérez-Guerrero EE; Godínez-Rubí M; Villegas-Pineda JC; Villanueva-Pérez MA; Sierra-Díaz E; Zepeda-Nuño JS; Pereira-Suárez AL; Ramírez-de-Arellano A
Front Endocrinol (Lausanne); 2024; 15():1333284. PubMed ID: 38370352
[TBL] [Abstract] [Full Text] [Related]
3. Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer.
He P; Yu H; Deng X; Xin L; Xu B; Zhou HB; Dong C
Eur J Med Chem; 2024 Mar; 268():116236. PubMed ID: 38367494
[TBL] [Abstract] [Full Text] [Related]
4. Treatments Targeting the Androgen receptor and Its Splice Variants in Breast cancer.
Tien AH; Sadar MD
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339092
[TBL] [Abstract] [Full Text] [Related]
5. Mechanism study of cross presentation of exogenous antigen induced by cholera toxin-like chimeric protein.
He X; Fan K; Gong H; Huang M; Zeng Q; Huang J; Peng X; Lai P; Lu Y; Wang H
Vaccine; 2024 Mar; 42(7):1549-1560. PubMed ID: 38320931
[TBL] [Abstract] [Full Text] [Related]
6. Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells.
Tao Y; Lu J; Li L; Lu L; Fu B; Zhang J; Zhang S; Ma R; Ma J; Sun J; Fu S; Liu S; Wang Z
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119684. PubMed ID: 38301906
[TBL] [Abstract] [Full Text] [Related]
7. Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of prostate cancer.
Jiang C; Xing J; Sanders A; Chidester K; Shi M; Perimbeti S; Deng L; Chatta GS; Gopalakrishnan D
JCO Oncol Pract; 2024 Apr; 20(4):509-516. PubMed ID: 38290084
[TBL] [Abstract] [Full Text] [Related]
8. New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling.
Erzurumlu Y; Dogan HK; Catakli D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23636. PubMed ID: 38229314
[TBL] [Abstract] [Full Text] [Related]
9. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
10. Adverse events and costs among non-metastatic castration-resistant prostate cancer patients.
Appukkuttan S; Yao J; Partridge J; Kong SX; Parkin J; Freedland SJ
J Med Econ; 2024; 27(1):145-152. PubMed ID: 38174553
[TBL] [Abstract] [Full Text] [Related]
11. Structure based docking and biological evaluation towards exploring potential anti-cancerous and apoptotic activity of 6-Gingerol against human prostate carcinoma cells.
Khan H; Azad I; Arif Z; Parveen S; Kumar S; Rais J; Ansari JA; Nasibullah M; Kumar S; Arshad M
BMC Complement Med Ther; 2024 Jan; 24(1):8. PubMed ID: 38166796
[TBL] [Abstract] [Full Text] [Related]
12. Potential impacts of bisphenols on prostate cells: An overview of cytotoxicity, proliferation, oxidative stress, apoptosis, and ER-stress response activation.
Caglayan M; Ozden S
Food Chem Toxicol; 2024 Feb; 184():114416. PubMed ID: 38134982
[TBL] [Abstract] [Full Text] [Related]
13. Androgen receptor-Interacting Proteins in prostate cancer Development and Therapy Resistance.
Culig Z; Puhr M
Am J Pathol; 2024 Mar; 194(3):324-334. PubMed ID: 38104650
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis and Preclinical Evaluation of PSMA-Targeted
Santos JF; Braz MT; Raposinho P; Cleeren F; Cassells I; Leekens S; Cawthorne C; Mendes F; Fernandes C; Paulo A
Mol Pharm; 2024 Jan; 21(1):216-233. PubMed ID: 37992229
[TBL] [Abstract] [Full Text] [Related]
15. Natural isoflavone glabridin targets PI3Kγ as an adjuvant to increase the sensitivity of MDA-MB-231 to tamoxifen and DU145 to paclitaxel.
Lin H; Ai D; Liu Q; Wang X; Chen Q; Hong Z; Tao Y; Gao J; Wang L
J Steroid Biochem Mol Biol; 2024 Feb; 236():106426. PubMed ID: 37984749
[TBL] [Abstract] [Full Text] [Related]
16. Radiometal Complexes as Pharmacokinetic Modifiers: A Potent
Schreck MV; Burgard C; Schmidtke A; Hierlmeier I; Stemler T; Maus S; Rosar F; Jung M; Speicher A; Ezziddin S; Holland JP; Bartholomä MD
Mol Pharm; 2023 Dec; 20(12):6463-6473. PubMed ID: 37978936
[TBL] [Abstract] [Full Text] [Related]
17. Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action.
Das S; Joshi P; Patra M
Inorg Chem; 2023 Dec; 62(48):19720-19733. PubMed ID: 37974075
[TBL] [Abstract] [Full Text] [Related]
18. Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer.
Li X; Bai Y; Feng K; Chu Z; Li H; Lin Z; Tian L
Pharmacol Rep; 2023 Dec; 75(6):1445-1453. PubMed ID: 37921966
[TBL] [Abstract] [Full Text] [Related]
19. Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis.
Ge Y; Jin J; Chen G; Li J; Ye M; Jin X
Cell Commun Signal; 2023 Oct; 21(1):303. PubMed ID: 37904149
[TBL] [Abstract] [Full Text] [Related]
20. RNF185 Control of COL3A1 Expression Limits prostate cancer Migration and Metastatic Potential.
Van Espen B; Oo HZ; Collins C; Fazli L; Molinolo A; Yip K; Murad R; Gleave M; Ronai ZA
Mol Cancer Res; 2024 Jan; 22(1):41-54. PubMed ID: 37831068
[TBL] [Abstract] [Full Text] [Related]
[Next]
